News Releases
- June 27, 2024Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
- June 26, 2024Annovis Bio Files Patent for New Composition of Matter for Buntanetap
- June 25, 2024Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
- June 18, 2024Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
- June 11, 2024Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
- June 5, 2024Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
- May 21, 2024Annovis Announces New Publication in a Peer-Reviewed Journal
- May 13, 2024Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
- May 9, 2024Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
- May 6, 2024Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Events & Presentations
-
Annovis Bio - Phase III PD Data
-
AD & PD Data Updates - July 2024
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top